Overview

  • Product name
    Anti-Respiratory Syncytial Virus antibody
    See all Respiratory Syncytial Virus primary antibodies
  • Description
    Goat polyclonal to Respiratory Syncytial Virus
  • Specificity
    No reaction with Influenza A&B, Para 1-3 and Adenovirus by IFA. Uninfected cell reactivity: Negative vs. WI38 cells or HEP2.
  • Tested applications
    Suitable for: ELISA, ICC/IF, Inhibition Assaymore details
  • Species reactivity
    Reacts with Human Respiratory Syncytial Virus.
  • Immunogen

    Respiratory Syncytial Virus isolate, confirmed.

Properties

Applications

Our Abpromise guarantee covers the use of ab20531 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA
ICC/IF
Inhibition Assay
  • Application notes
    ELISA: 1/10000.
    IF: 1/480.
    Inhib: 1/256 (Fusion Inhibition).

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Relevance
      Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children. RSV infection produces a variety of signs and symptoms involving different areas of the respiratory tract, from the nose to the lungs. RSV is a negative sense, enveloped RNA virus. The virion is variable in shape and size with average diameter of between 120 and 300 nm. The 63 kD RSV fusion protein of the RSS 2 strain (subtype A) directs fusion of viral and cellular membranes, results in viral penetration, and can direct fusion of infected cells with adjoining cells, resulting in the formation of syncytia or multi nucleated giant cells.
    • Cellular localization
      Virion. Host cytoplasm
    • Alternative names
      • RS virus antibody
      • RSV antibody

    References for Anti-Respiratory Syncytial Virus antibody (ab20531)

    This product has been referenced in:
    • McCutcheon KM  et al. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment. J Virol 90:1705-17 (2015). Read more (PubMed: 26608311) »
    • Fonseca W  et al. A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus. Arch Virol 159:1067-77 (2014). Read more (PubMed: 24292020) »

    See all 2 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab20531.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up